<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Research in Orthopedic Science</title>
<title_fa>Journal of Research in Orthopedic Science</title_fa>
<short_title>JROS</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jros.iums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2676-7031</journal_id_issn>
<journal_id_issn_online>2676-7031</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.32598/JROSJ</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The Efficacy of Platelet-Rich Plasma in the Treatment of Hemophilic Arthropathy</title>
	<subject_fa>جراحی زانو</subject_fa>
	<subject>Knee surgery</subject>
	<content_type_fa>پژوهشی</content_type_fa>
	<content_type>Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background&lt;/strong&gt;: The most clinical manifestation of hemophilia, as a congenital bleeding disorder, is the Intra-articular hemorrhage. The treatment of acute hemarthrosis with a sufficient amount of factor replacement will return the joint to the normal status.&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: This study aimed to evaluate the efficacy of platelet-rich plasma in the treatment of hemophilic arthropathy patients to reduce and improve their pain and physical function.&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Consecutive patients with hemophilic arthropathy were included in a self-control open-label trial in Mofid Children&amp;rsquo;s Hospital, Tehran, Iran. All participants received three platelet-rich plasma injections given two&amp;nbsp;weeks apart. Also, the seriate self-reported and objective clinical outcomes were evaluated before and three months after the treatment.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: A total of 11 patients with hemophilic arthropathy involving 14 joints received three injections of platelet-rich plasma at 2-week intervals, at our center. All patients were evaluated with a visual analog scale, the hemophilia joint health score, and the range of motion, and bleeding events, before and after the treatment. Finally, 9 boys (81.8%) and 2 girls (18.2%) completed the study. The mean age of the participants was 14.7 years (range, 9-19 years). In all patients, statistically significant improvements were noted on all evaluated measures.&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: Platelet-rich plasma therapy is a reasonable and minimally invasive procedure that includes beneficial chondro-regenerative properties.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Arthropathies, Platelet-Rich plasma, Prophylaxis, Synovitis, Hemophilia</keyword>
	<start_page>165</start_page>
	<end_page>168</end_page>
	<web_url>http://jros.iums.ac.ir/browse.php?a_code=A-10-693-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hoorieh</first_name>
	<middle_name></middle_name>
	<last_name>Davoodabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>peshgi64@gmail.com</email>
	<code>10031947532846003928</code>
	<orcid>10031947532846003928</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Childern’s Health, Shahid Beheshti University of Medical Sciences, Tehran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Malek</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fmalek7721@gmail.com</email>
	<code>10031947532846003929</code>
	<orcid>10031947532846003929</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Childern’s Health, Shahid Beheshti University of Medical Sciences, Tehran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Behnaz</first_name>
	<middle_name></middle_name>
	<last_name>Habibpanah</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>behnaz_panah@yaho.com</email>
	<code>10031947532846003930</code>
	<orcid>10031947532846003930</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Childern’s Health, Shahid Beheshti University of Medical Sciences, Tehran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abolfazl</first_name>
	<middle_name></middle_name>
	<last_name>Ghoojani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a.ghoojani@gmail.com</email>
	<code>10031947532846003931</code>
	<orcid>10031947532846003931</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Childern’s Health, Shahid Beheshti University of Medical Sciences, Tehran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
